Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward A Stadtmauer

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Seminars in Oncology|June 18, 2002
Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemiaEdward A Stadtmauer
Oncology (Williston Park, N.Y.)|June 4, 2010
Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myelomaEdward A Stadtmauer
The New England Journal of Medicine|December 26, 2003
Multiple myeloma, 2004--one or two transplants?Edward A Stadtmauer
Clinical Lymphoma|April 24, 2002
Trials with gemtuzumab ozogamicin (Mylotarg) combined with chemotherapy regimens in acute myeloid leukemiaEdward A Stadtmauer
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Proteasome inhibition for treatment of multiple myeloma: clinical updateEdward A Stadtmauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
A dramatic story of hope and realityEdward A Stadtmauer
The New England Journal of Medicine|January 24, 2024
Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple MyelomaEdward A Stadtmauer
Current Oncology Reports|August 7, 2002
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaEdward A Stadtmauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Poor-prognosis germ cell tumors: we have not yet crossed the finish lineDavid J Vaughn, Edward A Stadtmauer
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cellular and vaccine immunotherapy for multiple myelomaAlfred L Garfall, Edward A Stadtmauer
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Seminars in Oncology|June 18, 2002
Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemiaEdward A Stadtmauer
Oncology (Williston Park, N.Y.)|June 4, 2010
Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myelomaEdward A Stadtmauer
The New England Journal of Medicine|December 26, 2003
Multiple myeloma, 2004--one or two transplants?Edward A Stadtmauer
Clinical Lymphoma|April 24, 2002
Trials with gemtuzumab ozogamicin (Mylotarg) combined with chemotherapy regimens in acute myeloid leukemiaEdward A Stadtmauer
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Proteasome inhibition for treatment of multiple myeloma: clinical updateEdward A Stadtmauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
A dramatic story of hope and realityEdward A Stadtmauer
The New England Journal of Medicine|January 24, 2024
Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple MyelomaEdward A Stadtmauer
Current Oncology Reports|August 7, 2002
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaEdward A Stadtmauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Poor-prognosis germ cell tumors: we have not yet crossed the finish lineDavid J Vaughn, Edward A Stadtmauer
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cellular and vaccine immunotherapy for multiple myelomaAlfred L Garfall, Edward A Stadtmauer
Pageof 20